Type of security: Stock
Sector: Health Care
Industry: Major Pharmaceuticals
The data is delayed by 15 minutes.
CATB is in the medium-term down -35% below S&P in 2 months.
See how to gain 20% in 14 sec with TrendsInvesting
|Shares Outstanding||EPS||EPS Growth - 4 Quarters||EPS Growth - Q/Q|
|EPS Growth - Y/Y||Sales Growth - 4 Quarters||Sales Growth - Q/Q||P/E|
|P/E To EPS Growth||P/S||P/BV||Price/Cash Per Share|
|Price/Free Cash Flow||ROA||ROE||ROI|
|Current Ratio||Quick Ratio||Long Term Debt/Equity||Debt Ratio|
|Gross Margin||Operating Margin||Net Profit Margin||Dividend Payout Ratio|
|Cash From Financing Activities||16.89 M||Cash From Investing Activities||-30 K||Cash From Operating Activities||-7.23 M||Gross Profit|
|Net Profit||-6.5 M||Operating Profit||-6.36 M||Total Assets||26.73 M||Total Current Assets||24.85 M|
|Total Current Liabilities||4.99 M||Total Debt||9.66 M||Total Liabilities||13.45 M||Total Revenue|
|High 52 week||8.72||Low 52 week||0.62||Last close||6.05||Last change||-1.63%|
|RSI||58.02||Average true range||0.47||Beta||0.84||Volume||118.47 K|
|Simple moving average 20 days||2.14%||Simple moving average 50 days||7.61%||Simple moving average 200 days||38.74%|
|Performance Week||2.89%||Performance Month||21.73%||Performance Quart||-11.68%||Performance Half||860.32%|
|Performance Year||326.06%||Performance Year-to-date||38.44%||Volatility daily||4.35%||Volatility weekly||9.73%|
|Volatility monthly||19.94%||Volatility yearly||69.09%||Relative Volume||481.52%||Average Volume||333.3 K|
|New High||New Low|
2019-03-18 09:02:01 | Rising P/E an Overlooked Criterion: 5 Top Stocks
2019-03-14 18:09:10 | Edited Transcript of CATB earnings conference call or presentation 14-Mar-19 12:30pm GMT
2019-03-14 08:30:12 | Catabasis CATB Beats Earnings in Q4, Revenues Nil
2019-03-13 08:00:00 | Catabasis Pharmaceuticals to Present at Oppenheimer’s 29th Annual Healthcare Conference
2019-03-08 09:54:02 | Townsquare TSQ to Report Q4 Earnings: What's in the Cards?
2019-03-07 08:57:01 | Athersys ATHX Q4 Earnings: What's in Store for the Stock?
2019-03-07 08:51:01 | Is a Beat in Store for Catabasis CATB This Earnings Season?
2019-03-06 13:56:33 | Investors Who Bought Catabasis Pharmaceuticals Shares Three Years Ago Are Now Down 93%
2019-02-14 08:00:00 | Catabasis Pharmaceuticals Appoints Joanne T. Beck to its Board of Directors
2019-02-06 09:00:00 | Catabasis Pharmaceuticals Announces Pricing of $20 Million Underwritten Public Offering
2019-02-05 16:01:00 | Catabasis Pharmaceuticals Announces Proposed Underwritten Public Offering
2019-01-29 07:55:00 | New Research: Key Drivers of Growth for Tiffany, CarMax, Cars, RPC, Cleveland-Cliffs, and Catabasis Pharmaceuticals — Factors of Influence, Major Initiatives and Sustained Production
2019-01-15 11:10:39 | Is Catabasis Pharmaceuticals, Inc.’s NASDAQ:CATB CEO Overpaid Relative To Its Peers?
2019-01-14 01:42:06 | Catabasis Pharmaceuticals Sees Hammer Chart Pattern: Time to Buy?
2019-01-11 09:30:02 | Is Catabasis Pharmaceuticals CATB Outperforming Other Medical Stocks This Year?
2019-01-08 08:38:01 | Agenus AGEN Surges: Stock Moves 9.4% Higher
2019-01-04 08:00:00 | Catabasis Pharmaceuticals Appoints Gregg Lapointe to its Board of Directors
2018-12-31 16:31:00 | Why Canada Goose Holdings, Catabasis Pharmaceuticals, and Globalstar Jumped Today
2018-12-24 08:00:00 | Catabasis Pharmaceuticals Announces Reverse Stock Split
2018-12-12 02:22:00 | Catella and Söderberg & Partners in Strategic Partnership
2018-11-28 08:55:00 | Consolidated Research: 2018 Summary Expectations for MyoKardia, Bristow Group, The Chefs' Warehouse, Catabasis Pharmaceuticals, Casa, and EP Energy — Fundamental Analysis, Key Performance Indications
2018-11-15 09:26:38 | Does The Catabasis Pharmaceuticals Inc NASDAQ:CATB Share Price Fall With The Market?
2018-11-13 13:21:21 | Edited Transcript of CATB earnings conference call or presentation 13-Nov-18 1:30pm GMT
2018-11-13 08:15:42 | Catabasis Pharmaceuticals: 3Q Earnings Snapshot
2018-11-13 07:45:00 | Catabasis Pharmaceuticals Announces Collaboration with the University of Texas Southwestern to Explore the Potential Benefits of Edasalonexent on Cardiac Function in Duchenne and Becker Muscular Dystrophies
2018-10-18 08:25:00 | Recent Analysis Shows Progenics Pharmaceuticals, Catabasis Pharmaceuticals, Warrior Met Coal, Preformed Line Products, Express, and Sanmina Market Influences — Renewed Outlook, Key Drivers of Growth
2018-10-17 14:20:06 | Flagship biotech startup leases space from struggling Catabasis
2018-10-04 09:20:01 | Bet on Rising P/E Investing With These 5 Top-Ranked Stocks
2018-09-13 09:13:01 | Spectrum Pharma Includes First-Line NSCLC in Poziotinib Study
2018-08-27 07:45:00 | Recent Analysis Shows KalVista Pharmaceuticals, IZEA, Sonic Automotive, Catabasis Pharmaceuticals, ANI Pharmaceuticals, and Clovis Oncology Market Influences — Renewed Outlook, Key Drivers of Growth
2018-08-09 09:48:13 | Catabasis Pharmaceuticals: 2Q Earnings Snapshot
2018-08-09 06:30:00 | Catabasis Pharmaceuticals Inc to Host Earnings Call
2018-08-08 08:00:00 | Catabasis Pharmaceuticals to Present at 2018 Wedbush PacGrow Healthcare Conference
2018-07-26 08:00:00 | Free Technical Insights on BioPharmX and Three Other Biotech Stocks